Increasing access to contraceptive choice through targeted incentives: a cluster randomized controlled trial

How to cite

Paramo, Carlos; Dieci, Maria; Gertler, Paul. 2022. "Increasing access to contraceptive choice through targeted incentives: a cluster randomized controlled trial." AEA RCT Registry. AEARCTR-0009020. https://doi.org/10.1257/rct.9020-2.0

Download: BibTeX · RIS — for reference managers without a browser translator. Zotero and most others pick up this page's citation metadata directly.

Carlos Paramo* , Maria Dieci , Paul Gertler

* Primary investigator

Registry ID
AEARCTR-0009020
DOI
https://doi.org/10.1257/rct.9020-2.0
First registered
Last updated
Status
In development
Trial dates
2022-04-04 – 2024-06-01
Countries
Private
Registry record
http://www.socialscienceregistry.org/trials/9020

Abstract

We investigate how targeted subsidies and information campaigns for long-acting injectable contraception (Sayana Press) and provider incentives impact initial uptake of Sayana Press, pricing and stocking decisions for contraceptive products in local markets, and sales. Following prior work on the effectiveness of subsidies to promote the adoption of new technologies and experience goods, we aim to test if subsidies lead to the adoption of Sayana Press as well as to study possible mechanisms such as learning, price channels, and information effects. We use a cluster randomized controlled trial in a network of independent pharmacies. Patient subsidies and pharmacist incentives will be randomized and compared against the status quo to evaluate their effectiveness in promoting adoption.

Intervention

There will be 4 arms that will be randomized at the pharmacy (site) level. All sites will be users of a digital point-of-sale inventory management platform. Total subsidy and incentive amounts will be constant across 2 arms (T1 and T2) and higher for T3 (there is no financial incentive in the control arm).

(1) Control arm (C): pharmacy is an active user of the basic sales and inventory management digital platform, and pharmacy manages own stock of contraceptives.
(2) Patient subsidy arm (T1): The price of Sayana Press will be subsidized for the patient (50-80% subsidy).
(3) Pharmacy cost-reduction arm (T2): Providers will receive an incentive for each Sayana Press sale made, while being able to set their own prices.
(4) Pharmacy incentive arm (T3): Providers will receive a larger incentive relative to T1 and T2 for each Sayana Press sale made.

Experimental design

A sample of 137 eligible independent pharmacies in Western Kenya will be randomized into 4 study arms: (1) Control arm (2) Patient subsidy arm (3) Pharmacy cost-reduction arm (T2), and (4) Pharmacy incentive arm (T3).

Design details

Randomization method
Stratified randomization. Random seed will be set to equal the UC Berkeley IRB protocol number for the trial.
Randomization unit
Cluster-level randomization at the pharmacy level stratified by current stocks of Sayana Press, Family Planning sale volumes and urbanicity.
Clusters
137 Pharmacies
Observations
21,600 family planning product-transactions.
Arms
35 control sites, 35 patient subsidy sites, 33 pharmacy pharmacy cost-reduction sites, 36 pharmacy incentive sites.
Primary outcomes
The primary outcome is the uptake of Sayana Press.
Secondary outcomes
Sales and prices of other contraceptive products, markups charged by pharmacies, and stocking of Sayana Press in study sites.

Cited by

No citation data available for this registration yet.

Keywords